HESTERBIO HESTER BIOSCIENCES LTD.
Healthcare
LTP
2,299.8
CHG · %
-6.8 (-0.29%)
VOL · TODAY
1.98K
PREV CLOSE
2,306.6
Today's range2,263.9 · 2,328.5
2,299.8
52-week range1,239.3 · 2,683.6
2,299.8
Loading candles…
Hester Biosciences Ltd, incorporated in 1987 by founder Rajiv Gandhi, operates in the animal health care and veterinary vaccine industries. The company manufactures and distributes vaccines and health products for poultry and livestock through four main business segments: Poultry Vaccines, Poultry Health Products, Animal Vaccines, and Animal Health Products. Its product range includes poultry and animal vaccines, health products, seroprofiling kits, diagnostic labs for poultry flocks, and mastitis control programs for cattle. Hester Biosciences serves markets in India, Nepal, Tanzania, and over 30 other countries. The company holds approximately 75% market share as the world’s largest manufacturer of the Peste des Petits Ruminants (PPR) vaccine, about 70% share in India's Goat Pox vaccine market, and is the second largest poultry vaccine manufacturer in India with nearly 35% market share. Its ventures include partnerships with the Bill & Melinda Gates Foundation, GALVmed, Golchha Organisation, and Novapharma.
HESTERBIO is not part of any active scan today.
This page is a live market overview for HESTER BIOSCIENCES LTD. (HESTERBIO) on the BSE. As a listed security, HESTER BIOSCIENCES LTD. is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for HESTERBIO before placing trades on tick2trade.
As of the latest feed, HESTERBIO last traded at ₹2,299.8 on BSE, down ₹6.8 (0.29%) from the previous close of ₹2,306.6. Today's session range is ₹2,263.9 – ₹2,328.5, against a 52-week band of ₹1,239.3 – ₹2,683.6. Traded volume today stands at 1.98K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for HESTERBIO in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether HESTERBIO is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for HESTER BIOSCIENCES LTD. before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in HESTERBIO. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated HESTERBIO option chain page linked from this overview.
// similar in healthcare326 total